Research Alliance Corp III to merge with Oak Hill Bio in a $160M deal
Research Alliance Corp III agreed to merge with Oak Hill Bio, a Health Care company, at a headline value of $160M.
The agreement was announced on Monday 27 July, and we hold no shareholder vote date for it yet.
A $55M PIPE is recorded alongside the deal, though no filing we hold states it.
RACC dossier The deal 0001193125-26-3169540001193125-26-346912